|6.78||-0.18 / -2.59%|
Data as of 3:59pm ET
|6.78||0.00 / 0.00%|
The 9 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +76.99% increase from the last price of 6.78.
The current consensus among 9 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.